Literature DB >> 9874407

The treatment of lymphedema.

E Földi1.   

Abstract

BACKGROUND: Before the treatment of arm lymphedema after breast carcinoma treatment with complex decongestive physiotherapy can be initiated, it is mandatory to differentiate between benign and malignant forms (due to relapse) and to establish the diagnosis of accompanying diseases, if present.
METHODS: In benign lymphedemas, the aim of complex decongestive physiotherapy is to restore the symptom free "Stage 0 of latency" and to maintain fitness for work. The palliative treatment of malignant lymphedemas results in the amelioration of the quality of life.
RESULTS: The results of treatment depend on the experience of the physician in clinical lymphology, on the training and dedication of the lymphedema therapist, and on the compliance of the patient.
CONCLUSIONS: A study concerning gene expression has shown that complex decongestive physiotherapy influences the pathological alterations of the interstitium in lymphedema patients.

Entities:  

Mesh:

Year:  1998        PMID: 9874407     DOI: 10.1002/(sici)1097-0142(19981215)83:12b+<2833::aid-cncr35>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

1.  An integrated therapy concept for reduction of postoperative complications after resection of a panniculus morbidus.

Authors:  Georgios Koulaxouzidis; Sebastian M Goerke; Steffen U Eisenhardt; Florian Lampert; G Bjoern Stark; Etelka Foeldi; Nestor Torio-Padron
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

2.  Possible genetic predisposition to lymphedema after breast cancer.

Authors:  Beth Newman; Felicity Lose; Mary-Anne Kedda; Mathias Francois; Kaltin Ferguson; Monika Janda; Patsy Yates; Amanda B Spurdle; Sandra C Hayes
Journal:  Lymphat Res Biol       Date:  2012-03-09       Impact factor: 2.589

3.  Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9.

Authors:  Joseph M Rutkowski; Monica Moya; Jimmy Johannes; Jeremy Goldman; Melody A Swartz
Journal:  Microvasc Res       Date:  2006-07-28       Impact factor: 3.514

Review 4.  Compression garments and exercise: garment considerations, physiology and performance.

Authors:  Braid A MacRae; James D Cotter; Raechel M Laing
Journal:  Sports Med       Date:  2011-10-01       Impact factor: 11.136

Review 5.  Manual lymphatic drainage for lymphedema following breast cancer treatment.

Authors:  Jeanette Ezzo; Eric Manheimer; Margaret L McNeely; Doris M Howell; Robert Weiss; Karin I Johansson; Ting Bao; Linda Bily; Catherine M Tuppo; Anne F Williams; Didem Karadibak
Journal:  Cochrane Database Syst Rev       Date:  2015-05-21

Review 6.  A systematic review of the effect of low-level laser therapy in the management of breast cancer-related lymphedema.

Authors:  Mohammed Taher Ahmed Omar; Afaf Ahmed Mohamed Shaheen; Hamayun Zafar
Journal:  Support Care Cancer       Date:  2012-08-09       Impact factor: 3.603

7.  Lymphoedema and health-related quality of life by early treatment in long-term survivors of breast cancer. A comparative retrospective study up to 15 years after diagnosis.

Authors:  Katarina Y Karlsson; Imke Wallenius; Lena B Nilsson-Wikmar; Henrik Lindman; Birgitta B K Johansson
Journal:  Support Care Cancer       Date:  2015-03-06       Impact factor: 3.603

8.  [Medication-based therapy of infantile hemangioma and lymphatic malformations].

Authors:  J Rössler; F Braunschweiger; T Schill
Journal:  HNO       Date:  2014-01       Impact factor: 1.284

9.  Lymphedema secondary to limited cutaneous systemic sclerosis.

Authors:  Sónia Moreira; Jorge Crespo; Lèlita Santos
Journal:  BMJ Case Rep       Date:  2018-06-15

10.  An Integrative Therapeutic Concept for Surgical Treatment of Severe Cases of Lymphedema of the Lower Extremity.

Authors:  Jurij Kiefer; Georgios Koulaxouzidis; G Björn Stark; Etelka Foeldi; Nestor Torio-Padron; Vincenzo Penna
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.